Vanguard Group’s Biodesix BDSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Sell |
3,793,368
-30,322
| -0.8% | -$8.55K | ﹤0.01% | 3725 |
|
|
2025
Q1 | $2.39M | Hold |
3,823,690
| – | – | ﹤0.01% | 3434 |
|
|
2024
Q4 | $5.85M | Buy |
3,823,690
+861,000
| +29% | +$1.32M | ﹤0.01% | 3210 |
|
|
2024
Q3 | $5.27M | Buy |
2,962,690
+56,186
| +2% | +$100K | ﹤0.01% | 3256 |
|
|
2024
Q2 | $4.45M | Buy |
2,906,504
+2,098,576
| +260% | +$3.21M | ﹤0.01% | 3305 |
|
|
2024
Q1 | $1.16M | Sell |
807,928
-3,823
| -0.5% | -$5.47K | ﹤0.01% | 3762 |
|
|
2023
Q4 | $1.49M | Sell |
811,751
-210,088
| -21% | -$387K | ﹤0.01% | 3702 |
|
|
2023
Q3 | $1.69M | Sell |
1,021,839
-270,600
| -21% | -$446K | ﹤0.01% | 3645 |
|
|
2023
Q2 | $1.59M | Buy |
1,292,439
+61,597
| +5% | +$75.8K | ﹤0.01% | 3737 |
|
|
2023
Q1 | $2.29M | Buy |
1,230,842
+124,439
| +11% | +$231K | ﹤0.01% | 3625 |
|
|
2022
Q4 | $2.54M | Buy |
1,106,403
+866,747
| +362% | +$1.99M | ﹤0.01% | 3577 |
|
|
2022
Q3 | $305K | Buy |
239,656
+59,660
| +33% | +$75.9K | ﹤0.01% | 4341 |
|
|
2022
Q2 | $295K | Sell |
179,996
-39,957
| -18% | -$65.5K | ﹤0.01% | 4410 |
|
|
2022
Q1 | $372K | Sell |
219,953
-156,137
| -42% | -$264K | ﹤0.01% | 4441 |
|
|
2021
Q4 | $1.99M | Buy |
376,090
+132
| +0% | +$698 | ﹤0.01% | 4040 |
|
|
2021
Q3 | $3.09M | Buy |
375,958
+11,823
| +3% | +$97.2K | ﹤0.01% | 3905 |
|
|
2021
Q2 | $4.81M | Buy |
364,135
+95,757
| +36% | +$1.26M | ﹤0.01% | 3631 |
|
|
2021
Q1 | $5.45M | Buy |
268,378
+38,607
| +17% | +$784K | ﹤0.01% | 3483 |
|
|
2020
Q4 | $4.63M | Buy |
+229,771
| New | +$4.63M | ﹤0.01% | 3395 |
|